Development and validation of an immune signature-based risk model for prognostic assessment in melanoma
Abstract Melanoma is a highly invasive malignancy with poor prognoses in advanced stages. Developing a risk model that can accurately assess prognosis and guide personalized treatment is crucial for improving the clinical management of melanoma. This study aims to develop and validate an immune-base...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2025-03-01
|
| Серии: | Scientific Reports |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1038/s41598-025-90917-0 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|